JP2010540517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540517A5 JP2010540517A5 JP2010526914A JP2010526914A JP2010540517A5 JP 2010540517 A5 JP2010540517 A5 JP 2010540517A5 JP 2010526914 A JP2010526914 A JP 2010526914A JP 2010526914 A JP2010526914 A JP 2010526914A JP 2010540517 A5 JP2010540517 A5 JP 2010540517A5
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- added
- lcms
- chcl
- acidified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99520207P | 2007-09-25 | 2007-09-25 | |
| US18868408P | 2008-08-12 | 2008-08-12 | |
| PCT/US2008/010971 WO2009042093A1 (en) | 2007-09-25 | 2008-09-22 | Hiv protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540517A JP2010540517A (ja) | 2010-12-24 |
| JP2010540517A5 true JP2010540517A5 (enExample) | 2012-11-29 |
Family
ID=40325396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010526914A Withdrawn JP2010540517A (ja) | 2007-09-25 | 2008-09-22 | Ｈｉｖプロテアーゼ阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100093811A1 (enExample) |
| EP (1) | EP2203420A1 (enExample) |
| JP (1) | JP2010540517A (enExample) |
| AU (1) | AU2008305678A1 (enExample) |
| CA (1) | CA2700132A1 (enExample) |
| WO (1) | WO2009042093A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2762582A1 (en) * | 2009-05-27 | 2010-12-02 | Merck Sharp & Dohme Corp. | Hiv protease inhibitors |
| WO2012055031A1 (en) * | 2010-10-28 | 2012-05-03 | Merck Canada Inc. | Hiv protease inhibitors |
| EP2632908B1 (en) * | 2010-10-29 | 2016-05-25 | Merck Canada Inc. | Sulfonamides as hiv protease inhibitors |
| EP2771332B1 (en) | 2011-10-26 | 2016-06-29 | Merck Canada Inc. | Thiophen and thiazol sulfonamid derivatives as HIV protease inhibitors for the treatment of AIDS |
| CA2882831A1 (en) | 2012-09-11 | 2014-03-20 | Merck Sharp & Dohme Corp. | Hiv protease inhibitors |
| WO2015013835A1 (en) | 2013-07-31 | 2015-02-05 | Merck Sharp & Dohme Corp. | Piperazine derivatives as hiv protease inhibitors |
| US9834526B2 (en) | 2013-12-19 | 2017-12-05 | Merck Sharp & Dohme Corp. | HIV protease inhibitors |
| US9994587B2 (en) | 2014-03-06 | 2018-06-12 | Merck Sharp & Dohme Corp. | HIV protease inhibitors |
| WO2015138220A1 (en) | 2014-03-10 | 2015-09-17 | Merck Sharp & Dohme Corp. | Piperazine derivatives as hiv protease inhibitors |
| EP3212196A4 (en) | 2014-10-29 | 2018-07-11 | Wisconsin Alumni Research Foundation | Boronic acid inhibitors of hiv protease |
| CN111356456A (zh) | 2017-01-23 | 2020-06-30 | 夏威夷大学 | 2-芳基磺酰胺基-iV-芳基乙酰胺衍生的Stat3抑制剂 |
| US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| IL111991A (en) * | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
| IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
| US7388008B2 (en) * | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| EP2121589A2 (en) * | 2006-12-18 | 2009-11-25 | University of Massachusetts | Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease |
-
2008
- 2008-09-22 WO PCT/US2008/010971 patent/WO2009042093A1/en not_active Ceased
- 2008-09-22 AU AU2008305678A patent/AU2008305678A1/en not_active Abandoned
- 2008-09-22 JP JP2010526914A patent/JP2010540517A/ja not_active Withdrawn
- 2008-09-22 US US12/523,200 patent/US20100093811A1/en not_active Abandoned
- 2008-09-22 EP EP08833679A patent/EP2203420A1/en not_active Withdrawn
- 2008-09-22 CA CA2700132A patent/CA2700132A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010540517A5 (enExample) | ||
| JP2012510524A5 (enExample) | ||
| JP2012506425A5 (enExample) | ||
| JP2007536288A5 (enExample) | ||
| JP2009530445A5 (enExample) | ||
| JP2006519232A5 (enExample) | ||
| JP2018502909A5 (enExample) | ||
| JP2006502178A5 (enExample) | ||
| CN102584795A (zh) | 一种克里唑替尼的制备方法 | |
| JP2007526383A5 (enExample) | ||
| JP2013515755A5 (enExample) | ||
| MA29690B1 (fr) | Procede de preparation de la 4beta-amino-4'-demethyl-4-desoxypodophyllotoxine | |
| JP2008540414A5 (enExample) | ||
| JP2010132661A5 (enExample) | ||
| CN101219976A (zh) | 1,4-丁二磺酸钠的制备方法 | |
| CN103073483B (zh) | 一种甲哌卡因及其光学对映体的制备方法 | |
| CN104725292A (zh) | 一种(s)(-)-氨磺必利的制备方法 | |
| CN102391170B (zh) | 一种n,n-二烯丙基-5-甲氧基色胺盐酸盐的制备方法 | |
| CY1111994T1 (el) | Νεα μεθοδος για την παρασκευη σουλφονυλπυρρολιων ως αναστολεις hdac | |
| CN103992241A (zh) | N-取代苯基甘氨酸的制备方法 | |
| JP2008517967A5 (enExample) | ||
| WO2009072139A8 (en) | Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof | |
| CN104910068A (zh) | 一种2-氰基异烟酸酰肼1.5对甲苯磺酸盐的合成方法 | |
| JP2005314260A5 (enExample) | ||
| JP2008125364A5 (enExample) |